Guardado en:
| Autores principales: | Kaitlin H. Wade, Nicholas J. Timpson, Fergus W. Hamilton, Naveed Sattar, David Carslake, George Davey Smith |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | https://onlinelibrary.wiley.com/doi/10.1002/oby.24056 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
From Weight Loss to Multimorbidity Prevention: Framing the Anticipated Contributions of SURMOUNT ‐ MMO
por: Naveed Sattar
Publicado: (2025)
por: Naveed Sattar
Publicado: (2025)
Association of glycaemic control with intraocular pressure in a large general population: Results from the UK Biobank
por: Qiaoling Liu, et al.
Publicado: (2024)
por: Qiaoling Liu, et al.
Publicado: (2024)
Progressive increases in adiposity and ectopic fat surrogates across glycaemic states highlight weight reduction as a key target for type 2 diabetes prevention, especially in younger people
por: Sabrina Scilletta, et al.
Publicado: (2025)
por: Sabrina Scilletta, et al.
Publicado: (2025)
Quantifying assumptions underlying peak oxygen consumption equations across the body mass spectrum
por: Vincent Busque, et al.
Publicado: (2024)
por: Vincent Busque, et al.
Publicado: (2024)
Trends in hospitalization for cardio‐renal disease and mortality in people with type 1 diabetes in England, 2009–2019
por: Naomi Holman, et al.
Publicado: (2024)
por: Naomi Holman, et al.
Publicado: (2024)
Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019
por: Naomi Holman, et al.
Publicado: (2025)
por: Naomi Holman, et al.
Publicado: (2025)
Response to “Response to review by Pan et al.”
por: Xin‐Hui Pan, et al.
Publicado: (2024)
por: Xin‐Hui Pan, et al.
Publicado: (2024)
The association between excess weight and COVID‐19 outcomes: An umbrella review
por: Jamie Matu, et al.
Publicado: (2024)
por: Jamie Matu, et al.
Publicado: (2024)
Detecting and managing the patient with chronic kidney disease in primary care: A review of the latest guidelines
por: Kaitlin J. Mayne, et al.
Publicado: (2024)
por: Kaitlin J. Mayne, et al.
Publicado: (2024)
MRI‐Based Genetic Studies Reveal Specific Genetic Variants and Disease Risks Associated With Fat Distribution Across Anatomical Sites
por: Altayeb Ahmed, et al.
Publicado: (2025)
por: Altayeb Ahmed, et al.
Publicado: (2025)
Glycaemic Control by Sociodemographic Factors in Adults With Type 1 Diabetes in England: Trends From 2007–2008 to 2023–2024
por: Muhammad Saleem Khan, et al.
Publicado: (2026)
por: Muhammad Saleem Khan, et al.
Publicado: (2026)
Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE‐ O trial
por: Hertzel C. Gerstein, et al.
Publicado: (2024)
por: Hertzel C. Gerstein, et al.
Publicado: (2024)
In which common chronic conditions can (or cannot) obesity and lifestyle factors explain higher concentrations of C‐reactive protein?
por: Jana J. Anderson, et al.
Publicado: (2024)
por: Jana J. Anderson, et al.
Publicado: (2024)
Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
por: Sheila Pintado-Cucarella
Publicado: (2016)
por: Sheila Pintado-Cucarella
Publicado: (2016)
Severe Obesity Management in a Large Academic Health System: A Retrospective Evaluation of Metabolic Bariatric Surgery Counselling Practices
por: Mustafa Naveed, et al.
Publicado: (2026)
por: Mustafa Naveed, et al.
Publicado: (2026)
Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model
por: Marga A. G. Helmink, et al.
Publicado: (2024)
por: Marga A. G. Helmink, et al.
Publicado: (2024)
Response to “Nutritional considerations with antiobesity medications”
por: Shaminie J. Athinarayanan
Publicado: (2024)
por: Shaminie J. Athinarayanan
Publicado: (2024)
New Horizons for the Ro Allison Indiana Dhurandhar Food Noise Inventory: Response to a Letter to the Editor
por: Misty A. W. Hawkins, et al.
Publicado: (2026)
por: Misty A. W. Hawkins, et al.
Publicado: (2026)
Response to the Letter to the Editor by Athinarayanan
por: Jaime P. Almandoz, et al.
Publicado: (2024)
por: Jaime P. Almandoz, et al.
Publicado: (2024)
Response to Akçay
por: Sydney Yurkow, et al.
Publicado: (2025)
por: Sydney Yurkow, et al.
Publicado: (2025)
Response to the Letter to the Editor by Bett et al.
por: Jaime P. Almandoz, et al.
Publicado: (2024)
por: Jaime P. Almandoz, et al.
Publicado: (2024)
Urinary polycyclic aromatic hydrocarbons and adult obesity among the US population: NHANES 2003–2016
por: Manthar Ali Mallah, et al.
Publicado: (2024)
por: Manthar Ali Mallah, et al.
Publicado: (2024)
Longitudinal associations between child discipline methods and physical growth patterns across preschool years
por: Rosa S. Wong, et al.
Publicado: (2024)
por: Rosa S. Wong, et al.
Publicado: (2024)
Response to Fitch and Huett‐Garcia
por: Hamlet Gasoyan, et al.
Publicado: (2024)
por: Hamlet Gasoyan, et al.
Publicado: (2024)
Response to Hayashi et al.
por: Corby K. Martin, et al.
Publicado: (2025)
por: Corby K. Martin, et al.
Publicado: (2025)
Response to Swoap et al.
por: Gwang‐woong Go, et al.
Publicado: (2025)
por: Gwang‐woong Go, et al.
Publicado: (2025)
Importance of targeting post‐prandial hyperglycaemia to achieve HbA1c goals in insulin glargine‐treated subphenotypes of type 2 diabetes
por: Wolfgang Landgraf, et al.
Publicado: (2025)
por: Wolfgang Landgraf, et al.
Publicado: (2025)
Therapeutic inertia in obesity management among people living with obesity from the perspective of general/family practitioners in Canada: A mixed‐methods study
por: David C. W. Lau, et al.
Publicado: (2024)
por: David C. W. Lau, et al.
Publicado: (2024)
Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed‐ratio basal insulin glucagon‐like peptide‐1 receptor agonist combinations?
por: Kevin Cowart, et al.
Publicado: (2025)
por: Kevin Cowart, et al.
Publicado: (2025)
Enfoque de la obesidad infantil desde la pediatría
por: Erika F. Hurtado-López
Publicado: (2014)
por: Erika F. Hurtado-López
Publicado: (2014)
Response to “Nutritional considerations with antiobesity medications”
por: Gabriela de Souza Bett, et al.
Publicado: (2024)
por: Gabriela de Souza Bett, et al.
Publicado: (2024)
Response to “Beyond Adherence: Unraveling Methodological Complexity in Comparative Weight Change Among Antidiabetic Agents”
por: Jessica G. Young, et al.
Publicado: (2026)
por: Jessica G. Young, et al.
Publicado: (2026)
Response to “The safety of semaglutide in patients with depression and obesity”
por: Robert F. Kushner, et al.
Publicado: (2024)
por: Robert F. Kushner, et al.
Publicado: (2024)
Response to “Weight‐loss drugs like Wegovy could lead to an increased risk of fragility fractures in population at risk”
por: Robert F. Kushner, et al.
Publicado: (2025)
por: Robert F. Kushner, et al.
Publicado: (2025)
A Randomised Feasibility Study Assessing Acute Physiological Responses to Weight Stigma in Women Living With Obesity
por: Adrian Brown, et al.
Publicado: (2026)
por: Adrian Brown, et al.
Publicado: (2026)
Obesity management from the perspectives of people living with obesity in Canada: A mixed‐methods study
por: David C. W. Lau, et al.
Publicado: (2024)
por: David C. W. Lau, et al.
Publicado: (2024)
Diabetic distal symmetric polyneuropathy: More than just “tingling in the feet”
por: David S. H. Bell, et al.
Publicado: (2025)
por: David S. H. Bell, et al.
Publicado: (2025)
Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men
por: Justine M. Mucinski, et al.
Publicado: (2025)
por: Justine M. Mucinski, et al.
Publicado: (2025)
Using Metabolic Testing to Personalize Behavioral Obesity Treatment
por: Leonard H. Epstein, et al.
Publicado: (2025)
por: Leonard H. Epstein, et al.
Publicado: (2025)
Response to “Stopping Spin at the Source: Learning From an Example in Obesity”
por: Huasheng Xiang, et al.
Publicado: (2026)
por: Huasheng Xiang, et al.
Publicado: (2026)
Ejemplares similares
-
From Weight Loss to Multimorbidity Prevention: Framing the Anticipated Contributions of SURMOUNT ‐ MMO
por: Naveed Sattar
Publicado: (2025) -
Association of glycaemic control with intraocular pressure in a large general population: Results from the UK Biobank
por: Qiaoling Liu, et al.
Publicado: (2024) -
Progressive increases in adiposity and ectopic fat surrogates across glycaemic states highlight weight reduction as a key target for type 2 diabetes prevention, especially in younger people
por: Sabrina Scilletta, et al.
Publicado: (2025) -
Quantifying assumptions underlying peak oxygen consumption equations across the body mass spectrum
por: Vincent Busque, et al.
Publicado: (2024) -
Trends in hospitalization for cardio‐renal disease and mortality in people with type 1 diabetes in England, 2009–2019
por: Naomi Holman, et al.
Publicado: (2024)